- Reduction of Disease Activity in Patient with Relapsing-Remitting Multiple Sclerosis after Switching to Teriflunomide from Interferon Beta
-
Shin KS, Park JG, Park MS
- KMID: 2153170
- J Korean Neurol Assoc.
- 2016 Feb;34(1):77-79.
- doi: 10.17340/jkna.2016.1.17
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Two Cases of Primary Sjogren's Syndrome Presenting as Relapsing-Remitting Multiple Sclerosis
-
Cho JH, Kim SM, Kim JH, Chu CK, Lee MH, Shin HW, Doh WY, Sunwoo IN
- KMID: 2343096
- J Korean Neurol Assoc.
- 2004 Aug;22(4):410-413.
Sjogren's syndrome is a slowly progressive autoimmune disorder that predominantly affects major exocrine glands, and may also involve the central nervous system (CNS). It is sometimes very difficult to differentiate... -
- CITED
-
- Close
- SHARE
-
- Close
- Changes in the Multiple Sclerosis Treatment Paradigm. What Do We Do Now and What Were We Doing Before?
-
Alonso R, Eizaguirre MB, Zavala L, Pita C, Silva B, Garcea O
- KMID: 2424176
- J Clin Neurol.
- 2018 Oct;14(4):487-491.
- doi: 10.3988/jcn.2018.14.4.487
BACKGROUND AND PURPOSE: The number of disease-modifying drugs (DMDs) available for treating relapsing-remitting multiple sclerosis is increasing. Numerous drugs have been approved since 2010 in South America, which has increased... -
- CITED
-
- Close
- SHARE
-
- Close
- Contingent Negative Variation Is Associated with Cognitive Dysfunction and Secondary Progressive Disease Course in Multiple Sclerosis
-
Uysal U, Idiman F, Idiman E, Ozakbas S, Karakas S, Bruce J
- KMID: 2287508
- J Clin Neurol.
- 2014 Oct;10(4):296-303.
- doi: 10.3988/jcn.2014.10.4.296
BACKGROUND AND PURPOSE: The relationship between contingent negative variation (CNV), which is an event-related potential, and cognition in multiple sclerosis (MS) has not been examined previously. The primary objective of... -
- CITED
-
- Close
- SHARE
-
- Close
- Flare Up Reaction During Provocation Test to Glatiramer Acetate in a Patient With Allergy to Interferon Beta1a
-
Minciullo , Calapai G, Gangemi S
- KMID: 2181085
- Allergy Asthma Immunol Res.
- 2014 Sep;6(5):467-469.
- doi: 10.4168/aair.2014.6.5.467
Glatiramer acetate (GA) is a synthetic amino acid polymer, used for relapsing-remitting multiple sclerosis. The most common adverse effect of GA is a skin reaction at the injection site with... -
- CITED
-
- Close
- SHARE
-
- Close
- Benign Multiple Sclerosis is Associated with Reduced Thinning of the Retinal Nerve Fiber and Ganglion Cell Layers in Non-Optic-Neuritis Eyes
-
Huang-Link YM, Fredrikson M, Link H
- KMID: 1894558
- J Clin Neurol.
- 2015 Jul;11(3):241-247.
- doi: 10.3988/jcn.2015.11.3.241
BACKGROUND AND PURPOSE: It is exceedingly difficult to differentiate benign multiple sclerosis (BMS) from relapsing-remitting multiple sclerosis (RRMS) based on clinical characteristics, neuroimaging, and cerebrospinal fluid tests. Optical coherence tomography... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Presentations and Phenotypic Spectrum of Multiple Sclerosis at a University Hospital in Saudi Arabia
-
Nazish S, Shahid R, Zafar A, Alshamrani F, Sulaiman A, Alabdali M, Aljaafari , Al Wabari , Alkhamis F
- KMID: 2415053
- J Clin Neurol.
- 2018 Jul;14(3):359-365.
- doi: 10.3988/jcn.2018.14.3.359
BACKGROUND AND PURPOSE: The objective of this study was to determine the frequencies of different clinical presentations and the phenotypic spectrum of multiple sclerosis (MS). METHODS: This cross-sectional study was performed... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Vitamin B12 and Folic Acid Supplementation on Serum Homocysteine, Anemia Status and Quality of Life of Patients with Multiple Sclerosis
-
Nozari E, Ghavamzadeh S, Razazian N
- KMID: 2444237
- Clin Nutr Res.
- 2019 Jan;8(1):36-45.
- doi: 10.7762/cnr.2019.8.1.36
Plasma homocysteine level and megaloblastic anemia status are two factors that can affect the quality of life of patients with multiple sclerosis (MS). We conducted this study to determine the... -
- CITED
-
- Close
- SHARE
-
- Close
